SLT Holdings’s Microbot Medical MBOT Stock Holding History

SLT Holdings’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,500	Closed	-$38.1K	–	159
2025 Q3	$38.1K	Buy	+12,500	New	+$39K	0.02%	138

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SLT Holdings's MBOT Position: Q4 2025 in Review

SLT Holdings sold out of Microbot Medical (MBOT) in Q4 2025, closing a stake of 12,500 shares — an estimated $38.1K sold.

SLT Holdings first reported a position in MBOT in Q3 2025 and held it in 1 quarter. The position peaked at $38.1K in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.

SLT Holdings reported no remaining Microbot Medical position as of Q4 2025 after selling out during the quarter.
SLT Holdings sold 12,500 Microbot Medical shares in Q4 2025, an estimated $38.1K.
SLT Holdings first reported a position in Microbot Medical in Q3 2025 and held it in 1 quarter.
SLT Holdings's Microbot Medical position peaked at $38.1K in Q3 2025.
70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.

Based on SLT Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.